Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 24.36 USD 1.29%
Market Cap: 3.3B USD

Perrigo Company PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Perrigo Company PLC
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Perrigo Company PLC
NYSE:PRGO
Operating Income
$237.9m
CAGR 3-Years
-27%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Income
$703.7m
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
14%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Income
-$64m
CAGR 3-Years
6%
CAGR 5-Years
-25%
CAGR 10-Years
-1%
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Income
€92.1m
CAGR 3-Years
179%
CAGR 5-Years
N/A
CAGR 10-Years
16%
Ovoca Bio PLC
LSE:OVB
Operating Income
-€4m
CAGR 3-Years
-5%
CAGR 5-Years
-11%
CAGR 10-Years
7%

Perrigo Company PLC
Glance View

Market Cap
3.3B USD
Industry
Pharmaceuticals

Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.

PRGO Intrinsic Value
65.19 USD
Undervaluation 63%
Intrinsic Value
Price

See Also

What is Perrigo Company PLC's Operating Income?
Operating Income
237.9m USD

Based on the financial report for Sep 28, 2024, Perrigo Company PLC's Operating Income amounts to 237.9m USD.

What is Perrigo Company PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-8%

Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Perrigo Company PLC have been -27% over the past three years , -10% over the past five years , and -8% over the past ten years .

Back to Top